- $29.62bn
- $43.55bn
- $16.31bn
REG - ConnectingExcellence - Appointment of Chief Performance & Growth Officer
AnnouncementRCS - Highlight Theraptcs. - BO-112 melanoma Phase 2b clinical trial results
AnnouncementREG - J.P. Morgan Sec PLC - Stabilisation Notice
AnnouncementREG-IQVIA Holdings Inc. IQVIA Announces Offering of Senior Notes
AnnouncementREG - Iqvia Inc. - Delisting of Notes
AnnouncementREG - Iqvia Inc. - Notice to Holders
AnnouncementREG - Iqvia Inc. - Conditional Notice Of Redemption
Announcement